The Asia-Pacific region, encompassing a diverse array of low-income countries, faces significant challenges in ensuring access to essential medicines. This paper examines the current state of access to essential medicines in these countries, highlighting the various factors that contribute to the disparity. It delves into the complexities of healthcare systems, economic barriers, and political influences that impact the availability and affordability of life-saving drugs. The analysis reveals that while there have been some advancements in increasing access, substantial gaps remain, particularly in rural and impoverished areas. The paper further discusses the role of international aid, pharmaceutical policies, and regional cooperation in addressing these challenges. It concludes with recommendations for improved access to essential medicines, emphasizing the importance of sustainable strategies that consider both immediate and long-term needs.
Johnson, J. Access to Essential Medicines in Low-Income Countries of Asia-Pacific. Asia-Pacific Medical Journal, 2019, 1, 1. https://doi.org/10.69610/j.amj.20190830
AMA Style
Johnson J. Access to Essential Medicines in Low-Income Countries of Asia-Pacific. Asia-Pacific Medical Journal; 2019, 1(1):1. https://doi.org/10.69610/j.amj.20190830
Chicago/Turabian Style
Johnson, James 2019. "Access to Essential Medicines in Low-Income Countries of Asia-Pacific" Asia-Pacific Medical Journal 1, no.1:1. https://doi.org/10.69610/j.amj.20190830
APA style
Johnson, J. (2019). Access to Essential Medicines in Low-Income Countries of Asia-Pacific. Asia-Pacific Medical Journal, 1(1), 1. https://doi.org/10.69610/j.amj.20190830
Article Metrics
Article Access Statistics
References
World Health Organization. (2000). The world health report 2000: Health systems: Improving performance. Geneva: World Health Organization.
World Health Organization. (2009). Equitable financing of health services – breaking down barriers. Geneva: World Health Organization.
World Health Organization. (2004). Promoting the rational use of medicines: Core components. Geneva: World Health Organization.
International Federation of Pharmaceutical Manufacturers and Associations. (2008). Access to essential medicines: Strengthening pharmaceutical systems in developing countries. Brussels: IFPMA.
World Bank. (2005). World Development Report 2006: Equity and development. Washington, DC: World Bank.
Park, J. W., So, A. G., Greenhalgh, T., & Byott, N. R. (2005). The intellectual property rights regime and access to essential medicines in developing countries. BMJ, 331(7528), 1109-1111.
Asian Development Bank. (2008). Improving access to essential medicines in the Pacific region. Manila: Asian Development Bank.
World Health Organization. (2013). World medicines situation 2013. Geneva: World Health Organization.
World Health Organization. (2003). Developing national drug policies: A guidebook. Geneva: World Health Organization.
World Health Organization. (2002). The selection and use of essential medicines. Geneva: World Health Organization.
World Health Organization. (2005). The World Health Report 2005: Make every mother and child count. Geneva: World Health Organization.